Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-26-002919
Filing Date
2026-03-30
Accepted
2026-03-30 06:50:09
Documents
1
Period of Report
2026-03-30

Document Format Files

Seq Description Document Type Size
1 BEPIROVIRSEN ACCEPTED FOR REVIEW IN CHINA a5265y.htm 6-K 41006
  Complete submission text file 0001654954-26-002919.txt   42261
Mailing Address 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG
Business Address 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG 44 20 8047 5000
GSK plc (Filer) CIK: 0001131399 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-15170 | Film No.: 26809917
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)